571 research outputs found

    POLYMORPHISM OF GENES RESPONSIBLE FOR THROMBOPHILIA AND THEIR INFLUENCE ON THE DEVELOPMENT OF THROMBOSIS IN CHILDREN

    Get PDF
    The article is devoted to the prevalence of polymorphism of genes responsible for thrombophilia among children. The study included 52 children with thrombosis and 59 children without thrombosis. Detects mutations factor V Leiden, G20210A prothrombin gene, the C677T mutation in the gene for 5,10-methylenetetrahydrofolate reductase and 4G/5G polymorphism of gene plasminogen activator inhibitor 1. Mutations thrombophilia markers are detected in 38 of 52 (73 %) children with thrombosis, and 36 of 59 (61 %) children without thrombosis (p=0,1). A combination of several mutations in genes had 38 of 69 (55 %) children having different polymorphisms. The highest percentage (86 %) of different combinations of mutations have children with venous thrombosis, wherein the presence of mutations in Factor V (Leiden) mutation and prothrombin gene was isolated, and in all cases with each other or combined with mutation of the MTHFR gene. The most significant in the development of thrombosis are the G20210A mutation in the prothrombin gene mutation and Leiden. An example of clinical thrombosis, the girl with the data mutations

    Antibodies raised against a Sunn bug (Eurygaster integriceps Put.) recombinant protease, rGHP3p2, can inhibit gluten‐hydrolyzing activity

    Get PDF
    Sunn pest or Sunn bug, Eurygaster integriceps Put., salivary gland proteases are responsible for the deterioration of wheat flour quality during dough mixing, resulting from gluten hydrolysis. These proteases are highly heterogeneous and show low sensitivity to most types of proteinaceous inhibitors, meaning that such inhibitors cannot be used to prevent gluten damage. The present study describes the generation of a specific peptide antibody, raised against the active center of the recombinant gluten-hydrolyzing protease (GHP3). The recombinant protein, encoding two repeats of the GHP3 sequence element involved in forming the S4 pocket and binding of substrate at position P4, was designed and expressed in Escherichia coli. The antibodies raised to this recombinant protein showed inhibitory activity against the GHP3 protease. The results indicate that it is possible to design specific antibodies to inhibit wheat-bug gluten-hydrolyzing proteases

    Impact of General Anesthesia and Antioxidants on Cognitive, Static and Locomotor Functions During Laparoscopic Cholecystectomy

    Get PDF
    Aim of the study:Β to reduce cognitive impairment during laparoscopic cholecystectomy by perioperative administration of drugs with antihypoxic and antioxidant effects under the control of stabilography.Β  Β Materials and methods.Β We studied the effect of general anesthesia and antioxidants on cognitive, static and locomotor functions during laparoscopic cholecystectomy. We studied 90 patients with acute calculous cholecystitis randomized into three experimental groups (n=30, each group). The control group was composed of 24 healthy individuals. Group 1 patients received no antioxidants, group 2 patients received the combination antioxidant drug (sodium fumarate+sodium chloride+potassium chloride+magnesium chloride) in the post-operative period, and group 3 patients received methylethylpyridinol. The patient groups were comparable in sex, age and type of inflammatory and destructive process in the gallbladder. Surgical intervention was performed under endotracheal anesthesia. Premedication with atropine and promedol was given, and anesthesia induction was carried out with propofol, fentanyl and suxamethonium. Sevoflurane, fentanyl andcisatracurium were employed to maintain anesthesia, analgesia and myorelaxation, respectively. The patients were examined before surgery, 24 and 48 hours after surgery. In the groups of patients who received antioxidant therapy, blood sampling for hematological and biochemical examinations was performed 30 min after the administration of antioxidants. Stabilographic studies and MoCA test (Montreal Scale) were performed before antioxidant administration prior to surgery and after surgery, on days 2 and 3.Β  Β Results.Β Neuropsychological testing revealed postoperative cognitive dysfunction on standard therapy which included impaired attention and concentration, executive function, memory, speech, visual constructional skills, abstract thinking, counting, and orientation (21 points on the MoCA scale versus 28–30 points for normal). We found that the pathogenetic factors of cognitive dysfunction included insufficient antioxidant protection, decreased TNF-Ξ± and elevated interleukin-18 levels along with an increased level of C-reactive protein in plasma, which manifested as activation of free-radical oxidation processes and reduced antioxidant system and performance of nonspecific resistance. Perioperative use of the combination antioxidant drug and methylethylpyridinol antioxidants reduced the frequency and severity of postoperative cognitive impairment in patients after laparoscopic cholecystectomy.Β  Β Conclusion.Β The most important pathogenetic factors of cognitive dysfunction after laparoscopic cholecystectomy include activation of free-radical oxidation, reduction of antioxidant defense system performance and lack of nonspecific resistance factors. Adding the combination antioxidant drug or methylethylpyridinol to the standard therapy reduces the intensity of radical oxygen species generation, maintains the antioxidant potential, activates production and secretion of nonspecific resistance factors, preventing the development and reducing the severity of cognitive disorders in the perioperative period. Neuropsychological testing and stabilographic examination allow identifying the risk of cognitive disorders in patients after laparoscopic cholecystectomy and provide a rationale for the use of antioxidant therapy for their prevention

    О Ρ€Π°Π±ΠΎΡ‚Π΅ сСминара «НСлинСйная Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠ°Β»

    Get PDF
    Π’ 2011β€”2012 Π³ΠΎΠ΄Π°Ρ… Π² Ρ€Π°ΠΌΠΊΠ°Ρ… Π½Π°ΡƒΡ‡Π½ΠΎ-ΠΎΠ±Ρ€Π°Π·ΠΎΠ²Π°Ρ‚Π΅Π»ΡŒΠ½ΠΎΠ³ΠΎ Ρ†Π΅Π½Ρ‚Ρ€Π° «НСлинСйная Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠ°Β» ΠΏΡ€ΠΎΠ΄ΠΎΠ»ΠΆΠΈΠ» Ρ€Π°Π±ΠΎΡ‚Ρƒ Π½Π°ΡƒΡ‡Π½Ρ‹ΠΉ сСминар, посвящСнный исслСдованиям повСдСния ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Π°ΠΌ Π°Π½Π°Π»ΠΈΠ·Π° динамичСских систСм. Π—Π° ΠΏΡ€ΠΎΡˆΠ΅Π΄ΡˆΠΈΠΉ ΡƒΡ‡Π΅Π±Π½Ρ‹ΠΉ Π³ΠΎΠ΄ Π½Π° Π½Π΅ΠΌ Π±Ρ‹Π»ΠΎ Π·Π°ΡΠ»ΡƒΡˆΠ°Π½ΠΎ Π±ΠΎΠ»Π΅Π΅ Ρ‚Ρ€ΠΈΠ΄Ρ†Π°Ρ‚ΠΈ сообщСний ΠΏΠΎ Ρ‚Π΅ΠΌΠ°Ρ‚ΠΈΠΊΠ΅ исслСдований Π½Π°ΡƒΡ‡Π½ΠΎ-ΠΎΠ±Ρ€Π°Π·ΠΎΠ²Π°Ρ‚Π΅Π»ΡŒΠ½ΠΎΠ³ΠΎ Ρ†Π΅Π½Ρ‚Ρ€Π°. НиТС прСдставлСны тСзисы Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ интСрСсных Π΄ΠΎΠΊΠ»Π°Π΄ΠΎΠ², ΠΏΡ€ΠΎΠ·Π²ΡƒΡ‡Π°Π²ΡˆΠΈΡ… Π½Π° сСминарС

    ВлияниС ΠΎΠ±Ρ‰Π΅ΠΉ анСстСзии ΠΈ антиоксидантов Π½Π° ΠΊΠΎΠ³Π½ΠΈΡ‚ΠΈΠ²Π½Ρ‹Π΅ ΠΈ стато-Π»ΠΎΠΊΠΎΠΌΠΎΡ‚ΠΎΡ€Π½Ρ‹Π΅ Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠΈ ΠΏΡ€ΠΈ лапароскопичСской холСцистэктомии

    Get PDF
    Β  Β Aim of the study:Β to reduce cognitive impairment during laparoscopic cholecystectomy by perioperative administration of drugs with antihypoxic and antioxidant effects under the control of stabilography.Β  Β Materials and methods.Β We studied the effect of general anesthesia and antioxidants on cognitive, static and locomotor functions during laparoscopic cholecystectomy. We studied 90 patients with acute calculous cholecystitis randomized into three experimental groups (n=30, each group). The control group was composed of 24 healthy individuals. Group 1 patients received no antioxidants, group 2 patients received the combination antioxidant drug (sodium fumarate+sodium chloride+potassium chloride+magnesium chloride) in the post-operative period, and group 3 patients received methylethylpyridinol. The patient groups were comparable in sex, age and type of inflammatory and destructive process in the gallbladder. Surgical intervention was performed under endotracheal anesthesia. Premedication with atropine and promedol was given, and anesthesia induction was carried out with propofol, fentanyl and suxamethonium. Sevoflurane, fentanyl andcisatracurium were employed to maintain anesthesia, analgesia and myorelaxation, respectively. The patients were examined before surgery, 24 and 48 hours after surgery. In the groups of patients who received antioxidant therapy, blood sampling for hematological and biochemical examinations was performed 30 min after the administration of antioxidants. Stabilographic studies and MoCA test (Montreal Scale) were performed before antioxidant administration prior to surgery and after surgery, on days 2 and 3.Β  Β Results.Β Neuropsychological testing revealed postoperative cognitive dysfunction on standard therapy which included impaired attention and concentration, executive function, memory, speech, visual constructional skills, abstract thinking, counting, and orientation (21 points on the MoCA scale versus 28–30 points for normal). We found that the pathogenetic factors of cognitive dysfunction included insufficient antioxidant protection, decreased TNF-Ξ± and elevated interleukin-18 levels along with an increased level of C-reactive protein in plasma, which manifested as activation of free-radical oxidation processes and reduced antioxidant system and performance of nonspecific resistance. Perioperative use of the combination antioxidant drug and methylethylpyridinol antioxidants reduced the frequency and severity of postoperative cognitive impairment in patients after laparoscopic cholecystectomy.Β  Β Conclusion.Β The most important pathogenetic factors of cognitive dysfunction after laparoscopic cholecystectomy include activation of free-radical oxidation, reduction of antioxidant defense system performance and lack of nonspecific resistance factors. Adding the combination antioxidant drug or methylethylpyridinol to the standard therapy reduces the intensity of radical oxygen species generation, maintains the antioxidant potential, activates production and secretion of nonspecific resistance factors, preventing the development and reducing the severity of cognitive disorders in the perioperative period. Neuropsychological testing and stabilographic examination allow identifying the risk of cognitive disorders in patients after laparoscopic cholecystectomy and provide a rationale for the use of antioxidant therapy for their prevention.Β   ЦСль исслСдования. Π£ΠΌΠ΅Π½ΡŒΡˆΠΈΡ‚ΡŒ ΠΊΠΎΠ³Π½ΠΈΡ‚ΠΈΠ²Π½Ρ‹Π΅ Π½Π°Ρ€ΡƒΡˆΠ΅Π½ΠΈΡ ΠΏΡ€ΠΈ лапароскопичСской холСцистэктомии ΠΏΡƒΡ‚Π΅ΠΌ ΠΏΠ΅Ρ€ΠΈΠΎΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΎΠ½Π½ΠΎΠ³ΠΎ назначСния ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ΠΎΠ², ΠΎΠ±Π»Π°Π΄Π°ΡŽΡ‰ΠΈΡ… антигипоксичСской ΠΈ антиоксидантной Π°ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒΡŽ ΠΏΠΎΠ΄ ΠΊΠΎΠ½Ρ‚Ρ€ΠΎΠ»Π΅ΠΌ стабилографии.Β  Β ΠœΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»Ρ‹ ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹. Π˜Π·ΡƒΡ‡ΠΈΠ»ΠΈ влияниС ΠΎΠ±Ρ‰Π΅ΠΉ анСстСзии ΠΈ антиоксидантов Π½Π° ΠΊΠΎΠ³Π½ΠΈΡ‚ΠΈΠ²Π½Ρ‹Π΅ ΠΈ стато-Π»ΠΎΠΊΠΎΠΌΠΎΡ‚ΠΎΡ€Π½Ρ‹Π΅ Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠΈ ΠΏΡ€ΠΈ лапароскопичСской холСцистэктомии. ОбслСдовали 90 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с острым ΠΊΠ°Π»ΡŒΠΊΡƒΠ»Π΅Π·Π½Ρ‹ΠΌ холСциститом, случайным ΠΎΠ±Ρ€Π°Π·ΠΎΠΌ Ρ€Π°Π·Π±ΠΈΡ‚Ρ‹Ρ… Π½Π° Ρ‚Ρ€ΠΈ ΠΎΠΏΡ‹Ρ‚Π½Ρ‹Π΅ Π³Ρ€ΡƒΠΏΠΏΡ‹ ΠΏΠΎ 30 Ρ‡Π΅Π»ΠΎΠ²Π΅ΠΊ Π² ΠΊΠ°ΠΆΠ΄ΠΎΠΉ. ΠšΠΎΠ½Ρ‚Ρ€ΠΎΠ»ΡŒΠ½ΡƒΡŽ Π³Ρ€ΡƒΠΏΠΏΡƒ составили 24 Π·Π΄ΠΎΡ€ΠΎΠ²Ρ‹Ρ… Π΄ΠΎΠ½ΠΎΡ€Π°. ΠŸΠ°Ρ†ΠΈΠ΅Π½Ρ‚Π°ΠΌ I ΠΎΠΏΡ‹Ρ‚Π½ΠΎΠΉ Π³Ρ€ΡƒΠΏΠΏΡ‹ антиоксиданты Π½Π΅ Π½Π°Π·Π½Π°Ρ‡Π°Π»ΠΈ, ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚Ρ‹ II Π³Ρ€ΡƒΠΏΠΏΡ‹ Π² послСопСрационном ΠΏΠ΅Ρ€ΠΈΠΎΠ΄Π΅ ΠΏΠΎΠ»ΡƒΡ‡Π°Π»ΠΈ ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚, содСрТащий натрия Ρ…Π»ΠΎΡ€ΠΈΠ΄, калия Ρ…Π»ΠΎΡ€ΠΈΠ΄, магния Ρ…Π»ΠΎΡ€ΠΈΠ΄Π° гСксагидрат, натрия Ρ„ΡƒΠΌΠ°Ρ€Π°Ρ‚ (ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡ€ΠΎΠ²Π°Π½Π½Ρ‹ΠΉ антиоксидантный ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚), Π° ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚Ρ‹ III Π³Ρ€ΡƒΠΏΠΏΡ‹ – мСтилэтилпиридинол. Π“Ρ€ΡƒΠΏΠΏΡ‹ Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ… Π±Ρ‹Π»ΠΈ сопоставимы ΠΏΠΎ ΠΏΠΎΠ»Ρƒ, возрасту ΠΈ Ρ„ΠΎΡ€ΠΌΠ°ΠΌ Π²ΠΎΡΠΏΠ°Π»ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎ-дСструктивного процСсса Π² ΠΆΠ΅Π»Ρ‡Π½ΠΎΠΌ ΠΏΡƒΠ·Ρ‹Ρ€Π΅. ΠžΠΏΠ΅Ρ€Π°Ρ‚ΠΈΠ²Π½ΠΎΠ΅ Π²ΠΌΠ΅ΡˆΠ°Ρ‚Π΅Π»ΡŒΡΡ‚Π²ΠΎ осущСствляли ΠΏΠΎΠ΄ ΡΠ½Π΄ΠΎΡ‚Ρ€Π°Ρ…Π΅Π°Π»ΡŒΠ½Ρ‹ΠΌ Π½Π°Ρ€ΠΊΠΎΠ·ΠΎΠΌ. ΠŸΡ€Π΅ΠΌΠ΅Π΄ΠΈΠΊΠ°Ρ†ΠΈΡŽ выполняли с ΠΏΠΎΠΌΠΎΡ‰ΡŒΡŽ Π°Ρ‚Ρ€ΠΎΠΏΠΈΠ½Π° ΠΈ ΠΏΡ€ΠΎΠΌΠ΅Π΄ΠΎΠ»Π°, Π° ΠΈΠ½Π΄ΡƒΠΊΡ†ΠΈΡŽ осущСствляли ΠΏΡ€ΠΎΠΏΠΎΡ„ΠΎΠ»ΠΎΠΌ, Ρ„Π΅Π½Ρ‚Π°Π½ΠΈΠ»ΠΎΠΌ ΠΈ листСноном. ΠΠ½Π΅ΡΡ‚Π΅Π·ΠΈΡŽ ΠΏΠΎΠ΄Π΄Π΅Ρ€ΠΆΠΈΠ²Π°Π»ΠΈ ΡΠ΅Π²ΠΎΡ„Π»ΡŽΡ€Π°Π½ΠΎΠΌ, аналгСзию – Ρ„Π΅Π½Ρ‚Π°Π½ΠΈΠ»ΠΎΠΌ, ΠΌΠΈΠΎΡ€Π΅Π»Π°ΠΊΡΠ°Ρ†ΠΈΡŽ β€” нимбСксом. Π‘ΠΎΠ»ΡŒΠ½Ρ‹Ρ… обслСдовали Π΄ΠΎ ΠΎΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΈ, Ρ‡Π΅Ρ€Π΅Π· 24 ΠΈ 48 часов послС ΠΎΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΈ. Π’ Π³Ρ€ΡƒΠΏΠΏΠ°Ρ… Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ…, ΠΏΠΎΠ»ΡƒΡ‡Π°Π²ΡˆΠΈΡ… Π°Π½Ρ‚ΠΈΠΎΠΊΡΠΈΠ΄Π°Π½Ρ‚Π½ΡƒΡŽ Ρ‚Π΅Ρ€Π°ΠΏΠΈΡŽ, Π·Π°Π±ΠΎΡ€ ΠΊΡ€ΠΎΠ²ΠΈ для гСматологичСских ΠΈ биохимичСских исслСдований ΠΏΡ€ΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ Ρ‡Π΅Ρ€Π΅Π· 30 ΠΌΠΈΠ½ послС ввСдСния антиоксидантов. БтабилографичСскиС исслСдования ΠΈ тСст МоБА (ΠœΠΎΠ½Ρ€Π΅Π°Π»ΡŒΡΠΊΠ°Ρ шкала) ΠΏΡ€ΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ ΠΏΠ΅Ρ€Π΅Π΄ Π²Π²Π΅Π΄Π΅Π½ΠΈΠ΅ΠΌ антиоксидантов Π΄ΠΎ ΠΎΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΈ ΠΈ послС ΠΎΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΈ β€” Π½Π° 2-Π΅ ΠΈ 3-ΠΈ сутки.Β  Β Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹. Π‘ ΠΏΠΎΠΌΠΎΡ‰ΡŒΡŽ нСйропсихологичСского тСстирования выявили послСопСрационныС ΠΊΠΎΠ³Π½ΠΈΡ‚ΠΈΠ²Π½Ρ‹Π΅ дисфункции Π½Π° Ρ„ΠΎΠ½Π΅ стандартной Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ: Π½Π°Ρ€ΡƒΡˆΠ΅Π½ΠΈΡ внимания ΠΈ Π΅Π³ΠΎ ΠΊΠΎΠ½Ρ†Π΅Π½Ρ‚Ρ€Π°Ρ†ΠΈΠΈ, ΠΈΡΠΏΠΎΠ»Π½ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠΉ Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠΈ, памяти, Ρ€Π΅Ρ‡ΠΈ, Π·Ρ€ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎ-конструктивных Π½Π°Π²Ρ‹ΠΊΠΎΠ², абстрактного ΠΌΡ‹ΡˆΠ»Π΅Π½ΠΈΡ, счСта ΠΈ ΠΎΡ€ΠΈΠ΅Π½Ρ‚Π°Ρ†ΠΈΠΈ (21 Π±Π°Π»Π» ΠΏΠΎ шкалС МоБА ΠΏΡ€ΠΎΡ‚ΠΈΠ² 28–30 Π±Π°Π»Π»ΠΎΠ² для Π½ΠΎΡ€ΠΌΡ‹). Установили, Ρ‡Ρ‚ΠΎ патогСнСтичСскими Ρ„Π°ΠΊΡ‚ΠΎΡ€Π°ΠΌΠΈ ΠΊΠΎΠ³Π½ΠΈΡ‚ΠΈΠ²Π½ΠΎΠΉ дисфункции являСтся Π½Π΅Π΄ΠΎΡΡ‚Π°Ρ‚ΠΎΡ‡Π½ΠΎΡΡ‚ΡŒ антиоксидантной Π·Π°Ρ‰ΠΈΡ‚Ρ‹, сниТСниС содСрТания ЀНО-Ξ± ΠΈ ΠΏΠΎΠ²Ρ‹ΡˆΠ΅Π½ΠΈΠ΅ содСрТания ΠΈΠ½Ρ‚Π΅Ρ€Π»Π΅ΠΉΠΊΠΈΠ½Π°-18 Π½Π° Ρ„ΠΎΠ½Π΅ ΡƒΠ²Π΅Π»ΠΈΡ‡Π΅Π½Π½ΠΎΠΉ ΠΊΠΎΠ½Ρ†Π΅Π½Ρ‚Ρ€Π°Ρ†ΠΈΠΈ Π‘-Ρ€Π΅Π°ΠΊΡ‚ΠΈΠ²Π½ΠΎΠ³ΠΎ Π±Π΅Π»ΠΊΠ° Π² ΠΏΠ»Π°Π·ΠΌΠ΅ ΠΊΡ€ΠΎΠ²ΠΈ, Ρ‡Ρ‚ΠΎ проявляСтся Π°ΠΊΡ‚ΠΈΠ²Π°Ρ†ΠΈΠ΅ΠΉ процСссов свободно-Ρ€Π°Π΄ΠΈΠΊΠ°Π»ΡŒΠ½ΠΎΠ³ΠΎ окислСния, сниТСниСм мощности антиоксидантной систСмы ΠΈ Ρ„Π°ΠΊΡ‚ΠΎΡ€ΠΎΠ² нСспСцифичСской рСзистСнтности. ΠŸΠ΅Ρ€ΠΈΠΎΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΎΠ½Π½ΠΎΠ΅ использованиС антиоксидантов ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡ€ΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ антиоксидантного ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π° ΠΈ мСтилэтилпиридинола сниТаСт частоту ΠΈ ΡΡ‚Π΅ΠΏΠ΅Π½ΡŒ выраТСнности послСопСрационных ΠΊΠΎΠ³Π½ΠΈΡ‚ΠΈΠ²Π½Ρ‹Ρ… Π½Π°Ρ€ΡƒΡˆΠ΅Π½ΠΈΠΉ Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² послС лапароскопичСской холСцистэктомии.Β  Β Π—Π°ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅. Π’Π°ΠΆΠ½Π΅ΠΉΡˆΠΈΠΌΠΈ патогСнСтичСскими Ρ„Π°ΠΊΡ‚ΠΎΡ€Π°ΠΌΠΈ формирования ΠΊΠΎΠ³Π½ΠΈΡ‚ΠΈΠ²Π½Ρ‹Ρ… дисфункций послС лапароскопичСской холСцистэктомии ΡΠ²Π»ΡΡŽΡ‚ΡΡ активация процСссов свободно-Ρ€Π°Π΄ΠΈΠΊΠ°Π»ΡŒΠ½ΠΎΠ³ΠΎ окислСния, сниТСниС мощности систСмы антиоксидантной Π·Π°Ρ‰ΠΈΡ‚Ρ‹, Π½Π΅Π΄ΠΎΡΡ‚Π°Ρ‚ΠΎΡ‡Π½ΠΎΡΡ‚ΡŒ Ρ„Π°ΠΊΡ‚ΠΎΡ€ΠΎΠ² нСспСцифичСской рСзистСнтности. Π’ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅ Π² ΡΡ‚Π°Π½Π΄Π°Ρ€Ρ‚Π½ΡƒΡŽ Ρ‚Π΅Ρ€Π°ΠΏΠΈΡŽ ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡ€ΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ антиоксидантного ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π° Π»ΠΈΠ±ΠΎ мСтилэтилпиридинола ΡƒΠΌΠ΅Π½ΡŒΡˆΠ°Π΅Ρ‚ ΠΈΠ½Ρ‚Π΅Π½ΡΠΈΠ²Π½ΠΎΡΡ‚ΡŒ образования Ρ€Π°Π΄ΠΈΠΊΠ°Π»ΡŒΠ½Ρ‹Ρ… Ρ„ΠΎΡ€ΠΌ кислорода, сохраняСт антиоксидантный ΠΏΠΎΡ‚Π΅Π½Ρ†ΠΈΠ°Π», Π°ΠΊΡ‚ΠΈΠ²ΠΈΡ€ΡƒΡŽΡ‚ синтСз ΠΈ ΡΠ΅ΠΊΡ€Π΅Ρ†ΠΈΡŽ Ρ„Π°ΠΊΡ‚ΠΎΡ€ΠΎΠ² нСспСцифичСской рСзистСнтности, прСдупрСТдая Ρ€Π°Π·Π²ΠΈΡ‚ΠΈΠ΅ ΠΈ ΡƒΠΌΠ΅Π½ΡŒΡˆΠ°Ρ Π²Ρ‹Ρ€Π°ΠΆΠ΅Π½Π½ΠΎΡΡ‚ΡŒ ΠΊΠΎΠ³Π½ΠΈΡ‚ΠΈΠ²Π½Ρ‹Ρ… расстройств Π² ΠΏΠ΅Ρ€ΠΈΠΎΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΎΠ½Π½ΠΎΠΌ ΠΏΠ΅Ρ€ΠΈΠΎΠ΄Π΅. НСйропсихологичСскоС тСстированиС ΠΈ стабилографичСскоС обслСдованиС позволяСт Π²Ρ‹ΡΠ²Π»ΡΡ‚ΡŒ риск развития ΠΊΠΎΠ³Π½ΠΈΡ‚ΠΈΠ²Π½Ρ‹Ρ… Π½Π°Ρ€ΡƒΡˆΠ΅Π½ΠΈΠΉ Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² послС лапароскопичСской холСцистэктомии ΠΈ ΠΏΡ€ΠΈΠΌΠ΅Π½ΡΡ‚ΡŒ для ΠΈΡ… прСдупрСТдСния Π°Π½Ρ‚ΠΈΠΎΠΊΡΠΈΠ΄Π°Π½Ρ‚Π½ΡƒΡŽ Ρ‚Π΅Ρ€Π°ΠΏΠΈΡŽ
    • …
    corecore